Comparison Between Iran And France Regarding Breast Cancer: How Population Age Structure Changes Cancer Age Structure, Incidence And Cancer Control Plan

Azadeh JOULAEE, Mahdieh Women`s Hospital, Shahid Beheshti University of Medical Science, Iran
KADIVAR M. 2 , ALRAN S. 3 , JOLAEI S. 4

1 Associate prof. of surgery, Breast Unit, Departement of surgery, Mahdieh Women`s Hospital, Shhid Beheshti University of Medical Science
2 Prof. of Pathology, Department of Pathology, Hazrate Rasool University hospital, Iran University of Medical Science, Tehran, Iran
3 Breast oncologyst Surgeon, Department of Braest and Gynecology Srgery, Curie Institute, Paris, France
4 Associate prof. of surgery, Breast Unit, Departement of surgery, Mahdieh Women`s Hospital, Shhid Beheshti University of Medical Science

As the most frequent women`s cancer, breast cancer is a health priority in developped countries since many years ago.National screening programme and better teratment has improved its prognosis. Because 25-28% of all female cancers is breast cancer, more than half of 1 700 000 global new cases are seen in developing countries where much lower incidence is compensated by higher population and higher mortality.
High price of technology depended screening, shortage of expert breast radiologist/interventionalist, low health budget and other health priorities are all against screening in these countries.
These barriers cannot be resolved quickly. Is there any way to bypass these limits toward international standars for breast cancer control in these countries? Still there is no answer for such an important health question.
In this study we try to compare breast cancer situation in Iran and France for similarities and differences that may help us to draw a correct cancer plan.
Material and Method:
Population and cancer age structure and cancer incidence were compared between Iran, Europe and France.
Then Iran age structure is transferred to France. Age specific cancer incidence of France (2012) is then applied to this new population age.
Results:
11% of Iranian population and 31% French are in screening age.Still 46% of cancers in Iran and 55% in France are in screening age. 89% of Iranaian population (86% less than 50) and 69% of french population are outside screening age with 54% of cancers in Iran and 45% in France.
By transfering Iran population (1.23 times to France) to France age specific incidence, the  total number of cancer droops from 48763 to 26986.(55%)
Coclusion:
Cancer incidence depends on population age structure. Interestingly improved breast care is the key that can improve prognosis without screening as is seen in patients outside screening age in France.